Giving you all the latest in Stock Market Information as it happens
 

Month: September 2011

Application for Quotation of Additional Securities

Crown ASX:CWN has announced details of a Buy Back, Dividend or New Issue. The notice entitled ‘Application for Quotation of Additional Securities’ was published on Friday 30 September 2011. Crown has issued similar announcements 41 times before, most recently about 0 minutes ago on Thursday 29 September 2011. The share price for Crown was 8.020 trending up at the time of the announcement. Notice Type: Share Buyback, Special Dividend, Issue, or Capital Return

Posted in Uncategorized

Appendix 3B Dividend Reinvestment Plan

Kingsgate Consolidated ASX:KCN has announced details of a Buy Back, Dividend or New Issue. The notice entitled ‘Appendix 3B Dividend Reinvestment Plan’ was published on Friday 30 September 2011. Kingsgate Consolidated has issued similar announcements 83 times before, most recently about 0 minutes ago on Friday 23 September 2011. The share price for Kingsgate Consolidated was 7.120 trending down at the time of the announcement. Notice Type: Share Buyback, Special Dividend, Issue, or Capital Return

Posted in Uncategorized

Ottery Drilling Results

CENTRAL WEST GOLD N.L. Central West Gold has issued similar announcements 11 times before, most recently about 0 minutes ago on Tuesday 12 July 2011. The announcement ‘Ottery Drilling Results’ was issued to the ASX on Friday 30 September 2011. The share price for Central West Gold was 0.059 trending up at the time of the announcement. Notice Type: Exploration Update

Posted in Uncategorized

Ottery Drilling Results

CENTRAL WEST GOLD N.L. Central West Gold has issued similar announcements 11 times before, most recently about 0 minutes ago on Tuesday 12 July 2011. The announcement ‘Ottery Drilling Results’ was issued to the ASX on Friday 30 September 2011. The share price for Central West Gold was 0.059 trending up at the time of the announcement. Notice Type: Exploration Update

Posted in Uncategorized

Sidi Dhaher-1 Erroneous Report

ASX Release 30 September 2011 ADX : Sidi Dhaher1 Well Dear Shareholders It has come to the attention of the Company that there has been an unsubstantiated and erroneous report issued recently, containing speculation and speculative analyses about results of the Sidi Dhaher1 exploration well located onshore Tunisia. AuDAX Resources has issued similar announcements 94 times before, most recently about 0 minutes ago on Friday 16 September 2011. The announcement ‘Sidi Dhaher1 Erroneous Report’ was issued to the ASX on Friday 30 September 2011. The share price for AuDAX Resources was 0.069 trending up at the time of the announcement. Notice Type: Exploration Update

Posted in Uncategorized

Change of Director`s Interest Notice (Mike Veverka)

Mike Veverka has acquired 73,629 fully paid ordinary shares at a value of 17,450 in JUMBO INTERACTIVE LIMITED ASX:JIN.Mike Veverka previously held 8,891,724 fully paid ordinary shares at a value of 17,450.The director now holds 8,965,353 fully paid ordinary shares at a value of 17,450. JUMBO INTERACTIVE LIMITED has issued similar announcements seven times before, most recently about 0 minutes ago on Friday 06 May 2011. The announcement ‘Change of Directors Interest Notice (mike Veverka)’ was issued to the ASX on Friday 30 September 2011. The share price for JUMBO INTERACTIVE LIMITED was 0.240 trending up at the time of the announcement. Notice Type: Directors Interest Notice Change

Posted in Uncategorized

Alchemia`s Cancer Treatment Shows Early Promise In Trial

Alchemias Cancer Treatment Shows Early Promise in Lung Cancer Trial Alchemia, Brisbane, Australia ( ACL) Alchemias lead cancer product from its HyACT technology, HAIrinotecan, was featured on Channel Seven News at 6pm yesterday in most regions, and was also featured on Sevens Sunrise program this morning (Wednesday 28th September) at 6.45am. The first two Small Cell Lung Cancer (SCLC) patients who received HAIrinotecan have responded very rapidly to the first dose, experiencing substantial shrinkage of their tumours after only ten days. Both patients were treated as part of a Phase II clinical study conducted at Monash Cancer Centre. The Principal Investigator of the trial Dr Vinod Ganju said We are excited by these early responses to treatment, mostly because of the speed of the tumour regressions.

Typically we would anticipate achieving a measurable response to therapy after one to two months of treatment but, in the case of the patients treated with HAIrinotecan, we could measure tumour shrinkage in a matter of days. Alchemia Oncologys Chief Scientific Officer, Professor Tracey Brown described these early responses as extremely encouraging whilst emphasizing that the effectiveness of the treatment will need to be confirmed with further patient data. The rapidity of the responses is consistent with results from preclinical studies of HAIrinotecan in lung cancer, she added. The current study is examining the effectiveness of HAIrinotecan, which utilises Alchemias patented HyACT technology to target the anticancer drug irinotecan to the tumour. Patients are randomized to receive either HAIrinotecan or irinotecan.

The parameters that are being assessed include safety and measures of effectiveness such as ProgressionFree Survival (PFS). In addition, the study will assess the impact of the treatments on circulating tumour cells (the number of cancer cells detected in the blood) and certain cell populations such as cancer stem cells in the tumour. Alchemias HyACT platform works by delivering a higher concentration of the drug to the tumour and enhancing the uptake of the drug by cancer cells. It achieves this by targeting the drug to a specific protein, CD44, that is expressed at high levels by the cells in solid cancers such as breast, lung and colorectal.

The technology has been shown to enhance the activity of a broad range of drugs across a number of preclinical models of different cancers. An earlier Phase II study in colorectal cancer with HAIrinotecan showed a statistically significant improvement in progressionfree survival compared with irinotecan (20.8 vs 9.6 weeks, p0.017). Recruitment to a pivotal Phase III study in colorectal cancer is expected to commence in 2011. For further details of the Phase II investigatorsponsored trial with inclusion and exclusion criteria please see the press release from September 9 available on Alchemias website www.alchemia.com.au Trial sites Peninsula Oncology Centre in Frankston Monash Cancer Centre, Southern Health, East Bentleigh For further details about the trial please contact Peter Midolo MSc Research Manager Medical Oncology Monash Medical Centre 865 Centre Rd East Bentleigh 3165 T 03 9928 8195 F 03 9928 8543 About Small Cell Lung Cancer There are approximately 220,000 new cases of lung cancer in the US, accounting for around 15% of all new cancer diagnoses and 28% of cancer deaths.

Of all lung cancer cases 1520% will be Small Cell Lung Cancer (SCLC) which is particularly aggressive with median survival from diagnosis of 24 months without treatment. Overall, small cell carcinoma of the lung is associated with the poorest prognosis of all types of lung cancer even with treatment, 5year survival is only 5%. SCLC responds well to chemotherapy but a cure is difficult to achieve because SCLC has a greater tendency to be widely disseminated by the time of diagnosis. About Alchemia Alchemia is a drug discovery and development Company founded on its chemistry expertise. The Companys first drug, fondaparinux (a generic version of GlaxoSmithKlines Arixtra, a synthetic anticoagulant mainly used for the prevention of deep vein thrombosis), has been launched by Dr Reddys Laboratories in the USA.

Alchemias pipeline of assets is built on two platform technologies HyACT (targeted cancer delivery) and VAST (drug discovery). The primary objective of the HyACT technology is to develop a new generation of anticancer drugs which demonstrate better efficacy. The lead product from the HyACT platform is HAIrinotecan for which a Phase III clinical trial has been prepared in metastatic colorectal cancer. Dosing of patients is expected to commence in 2011..

$1.5 million Loan Facility

Orion Gold NL 29 September 2011 $1.5 million Loan Facility Orion Gold NL ( ORN) is pleased to announce that it has finalised a $1.5 million loan agreement, providing the Company with funding to enable it to continue the diamond drilling program that has commenced to test highly ranked targets at New Dawn Toombon, Longfellows and Happy Go Lucky. The Company has entered into a loan agreement for up to $1.5 million (Facility) with Silja Investment Limited (Silja), the Companys major shareholder. Under the terms of the Facility, Silja has committed to convert cash drawn down under the Facility to shares, as part of a possible future capital raising subject to various conditions including Shareholder approval where required by law, including the ASX listing rules The capital raising including Siljas allocation being a minimum of $1.5 million The capital raising issue price of shares not being less than 1 cent per share and Siljas participation in the capital raising being an amount equivalent to Siljas proportionate shareholding in the Company (approximately 27%). Shares will be issued to Silja on the same terms as shares issued to other subscribers as part of a capital raising. The Facility expires on 30 June 2013, and the Company would be required to repay the Facility in cash on that date to the extent the loan balance has not been converted into shares by then. Under the terms of the Facility, a capital raising fee would be payable by the Company to Silja where it subscribes for its share allocation in a capital raising. The fee is calculated by multiplying the amount subscribed for by Silja under the terms of the Facility by the percentage commission payable to a broker or underwriter as part of the capital raising.

No facility fee is payable by the Company to Silja. Silja has a fixed and floating charge over the assets of the Company. Interest will be capitalised under the Facility at a margin of 1.5% over the 90day dealers bill rate (reset every 90 days). In order to draw on the Facility, the Company must meet certain conditions precedent including the continued employment of key personnel.

To date, the Company has not drawn on the Facility. Under the terms of the Facility, Siljas commitment to participate in a future capital raising as outlined above is in place irrespective of whether or not the Company utilises the Facility. Contact Company enquiries Suite 302 Level 3, 488 Bourke Street Denis Waddell Executive Chairman Melbourne VIC 3000 Martin Bouwmeester General ManagerCorporate T 61 3 8080 7170 F 61 3 8080 7174 E infooriongold.com.au Exploration Update The Company is also pleased to announce that the diamond drilling program has commenced to test highly ranked targets at New Dawn Toombon, Longfellows and Happy Go Lucky. The initial holes of the drill program are underway and are testing targets at New Dawn Toombon (Orion 85%) which is located on the recently reinterpreted Cohens trend. The Cohens trend hosts the major historical mines in the WalhallaWoods Point goldfield, with the recorded gold production from mines located along the Cohens trend totalling approximately 4 million ounces (see figure 1). The reinterpretation of the Cohens trend is an outcome of the Companys new structural model. Based on this model, Orion regards the New Dawn Toombon area as particularly prospective, as the historic workings are interpreted to be situated in the same stratigraphy and structural setting as the main Cohens Reef at Walhalla which produced 1.5 million ounces of gold.

Deposits in the New Dawn Toombon area are also interpreted to be similar in style to the mineralisation at Cohens Reef. The area has been subject to very little modern exploration and almost no drilling. Orions 3D model of the New Dawn workings, based upon the available historic data, provides targets for a series of parallel reefs and for southerly plunging intersection lodes (shoots). The current drill program totals 2,400 metres of diamond drilling with the first three holes (each of approximately 400 metres in length) to be drilled at New Dawn. Following the drill program at New Dawn, the Company will drill highly ranked targets at Longfellows and Happy Go Lucky (see figure 2). Continued review of the Companys outlying tenements utilising recent developments in interpretation of mineralisation controls, has led to a series of further, new and encouraging prospects being designated for field testing and possible drilling. The detailed study on the extensive historical data for the Cohens Reef deposit continues.

It is anticipated that targets will be identified for bulk tonnage, low grade and high grade shoots at Cohens. Also it is expected that regional targets will be identified resulting from this improved interpretation and understanding. The Company is expecting to be able to provide a more detailed update on the outcomes of the study in the coming weeks. Denis Waddell Executive Chairman.

Press Release – Award of New Precast Projects

KOON RIDES ON PRECAST DEMAND SECURES NEW PROJECTS WORTH S$53.73 MILLION To supply precast components for the construction of new Housing and Development Board (HDB) flats and a private industrial development project with an aggregate contract value of S$53.73 million Order book of the Precast division currently stands at approximately S$103.40 million Singapore and Australia, 29 September 2011 Koon Holdings Limited, (Koon, 23824255113292926377384802084421496 or the Group), one of Singapores leading infrastructure construction and precast specialists, is pleased to announce that it has secured new precast projects with an aggregate contract value of S$53.73 million. Highlights of the New Precast Projects Secured The HDB and private industrial development projects were secured through the Groups subsidiaries Econ Precast Pte Ltd (Econ) and Contech Precast Pte Ltd (Contech). Under the agreements, Econ and Contech will supply precast components over a contract period of 7 to 18 months. Both Econ and Contech have the highest license (L6) from the Building and Construction Authority of Singapore (BCA) which allows them to bid for precast concrete works in Singapore of unlimited contract value. Commenting on the new precast projects secured, Mr Tan Thiam Hee (384722815521916), Managing Director and Chief Executive Officer of Koon said, Our foray into this fastgrowing niche market is further validated as we increase our precast order book with these sizable precast projects. HDB recently initiated the largest supply of flats ever offered in a single launch with another 4,200 buildtoorder flats to be launched in November 2011. In line with the strong demand for public housing projects, precast products are gaining wider adoption as they simplify onsite construction process, provide better quality control and higher cost efficiencies. With the Singapore governments initiatives to increase productivity in constructionrelated activities, there is also a progressive adoption of precast products in private sector projects. Riding on the precast demand, our established precast subsidiaries are in a very strong position to meet the increased demand with our comprehensive range of precast products and manufacturing capabilities in our three manufacturing yards. These contracts are not expected to materially affect the Groups performance for the financial year ending 31 December 2011. Precast Order Book Update With the inclusion of these contracts, to date, Koons Precast order book (excluding the Construction division) stands at approximately S$103.40 million. Notably, in April 2011, the Group secured a S$16.3 million contract to design and supply precast components for public housing projects.

Since its foray into the precast market in March 2010, the Group has progressively secured new projects under its precast division. Mr Tan concluded, Our diversified business model will continue to set the pace for future growth while at the same time, we remain focused on creating synergies between our complementary business units especially between our Infrastructure Construction and Precast divisions. END This document is to be read in conjunction with Koons exchange filings on 29 September 2011, which can be downloaded via www.sgx.com and www.asx.com.au. Issued on behalf of Koon Holdings Limited by ShareInvestor Pte Ltd Media Investor Contact ShareInvestor Pte Ltd Koon Holdings Limited Mr Alex Tan Mr Ben Teo Direct Line 65 6517 8771 Mobile 65 9451 5252 Chief Financial Officer Tel 65 6261 5788 Fax 65 6266 0117 Email alex.tanshareinvestor.com Email irkoon.com.sg Website www.koon.com.sg.

RESOLUTE INITIATES SHARE BUYBACK PROGRAM

RESOLUTE INITIATES SHARE BUYBACK PROGRAM Resolute Mining Limited ( RSG, Resolute) is pleased to advise that its Board of Directors has resolved to initiate an onmarket share buyback program. Resolute Chief Executive Officer Peter Sullivan said The buyback is consistent with our previously stated intention to evaluate capital management programs for the benefit of all Resolute shareholders. Our expanding gold production and strengthening balance sheet has put Resolute in a position to opportunistically take advantage of the further upside value we believe exists in the Resolute shares. Up to 46.86 million shares, which represents up to 10% of the Companys current shares on issue, can be acquired by Resolute over the next 12 months as part of the buyback. It is expected the buyback will commence on or around 14th October 2011 at Resolutes discretion. An Appendix 3C in relation to the buyback is appended to this announcement. PETER SULLIVAN Chief Executive Officer About Resolute Resolute is an unhedged gold miner with three operating mines in Africa and Australia. The Company is the second largest gold producer by volume listed on the ASX and has forecast FY12 production of 410,000oz at a cash cost of $730/oz.

Resolute is targeting an increase in production from its flagship Syama project in Mali to 250,000oz of gold a year after an extended rampup and commissioning period. Resolute is currently investigating a number of opportunities to add value by increasing gold production and lowering operating costs at Syama and its Ravenswood operations in Queensland. The Company controls an extensive footprint in the highly prospective Syama Sheer and Greenstone Belts in Mali and Cote dIvoire.

Resolute has identified a number of promising exploration targets at its Ravenswood operations and holds a number of exploration projects in Tanzania surrounding its Golden Pride mine..